{
    "2018-12-04": [
        [
            {
                "time": "2018-12-04",
                "original_text": "恒瑞医药：获得临床试验通知书",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "临床试验",
                        "通知书"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-12-04",
                "original_text": "恒瑞医药：抗肿瘤药将进入三期临床试验",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "抗肿瘤药",
                        "三期临床试验"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-12-04",
                "original_text": "资金持续北上抄底 11月多只白马股获增持",
                "features": {
                    "keywords": [
                        "资金",
                        "北上",
                        "白马股",
                        "增持"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-04",
                "original_text": "明年冲入A股外资规模或达4000亿，国际大资管、华尔街大投行等“聪明钱”正密集调研这些个股！",
                "features": {
                    "keywords": [
                        "外资",
                        "A股",
                        "聪明钱",
                        "调研"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-04",
                "original_text": "恒瑞医药：将于近期开展SHR-1316注射液的III期临床试验 用于治疗恶性肿瘤",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "SHR-1316注射液",
                        "III期临床试验",
                        "恶性肿瘤"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-12-04",
                "original_text": "2019年医药行业选股思路：轻药重医将是主要方向",
                "features": {
                    "keywords": [
                        "医药行业",
                        "选股思路",
                        "轻药重医"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-12-04",
                "original_text": "集采冲击波：中国生物制药蒸发800亿市值，未来是否仍可期？ 连续下跌",
                "features": {
                    "keywords": [
                        "集采",
                        "中国生物制药",
                        "市值蒸发",
                        "连续下跌"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-12-04",
                "original_text": "放量上涨逾百亿元大单涌入A股，北上资金等三路资金现新动向",
                "features": {
                    "keywords": [
                        "放量上涨",
                        "北上资金",
                        "A股",
                        "资金流入"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-04",
                "original_text": "医药行业周报:仿制药格局变革、器械崛起,轻药重医",
                "features": {
                    "keywords": [
                        "医药行业",
                        "仿制药",
                        "器械崛起",
                        "轻药重医"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}